skip to Main Content

Chemoradiotherapy vs. chemotherapy for locally advanced pancreatic cancer

Newsfeed image, light gray text on dark gray background
Researchers have assessed whether chemoradiotherapy improves overall survival of patients with locally advanced pancreatic cancer controlled after four months of gemcitabine-based induction chemotherapy, and assessed the effect of erlotinib on survival. Gemcitabine and erlotinib are drugs used to treat cancer.

In locally advanced pancreatic cancer, the role of chemoradiotherapy is controversial and the efficacy of erlotinib is unknown. Read more . . .

Back To Top